Medicamen Biotech Limited (BSE: 531146)
Health Care · Pharmaceuticals · IN
Rs305.35
-3.16% today · -1.1% 1Y
Medicamen Biotech Limited (BSE: 531146) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $42.79M.
Over the last twelve months the share price has lost 1.1%, trading between 210.10 and 454.00.
Tweenvest scores Medicamen Biotech Limited across four factors: quality 66/100, value 68/100, growth 37/100, dividend 22/100. Its strongest factor is value.
531146 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $42.79M
- Revenue (TTM)
- $21.80M
- P/E
- 40.99
- EPS
- 7.45
- Dividend yield
- 0.33%
- Beta (5Y)
- 0.69
- 52-week high
- Rs454.00
- 52-week low
- Rs210.10
- Avg volume (3M)
- —
- Shares outstanding
- 13.56M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Avecho Biotechnology LimitedASX: AVE | $43.14M | AU$0.02 | -20.00% |
| Decibel Cannabis Company Inc.TSXV: DB | $43.14M | CA$1.60 | -4.76% |
| Jenburkt Pharmaceuticals LimitedBSE: 524731 | $43.09M | Rs945.00 | +2.12% |
| Sofgen Pharma S.A.OTCPK: PROC.F | $43.07M | $— | — |
| Hayat Pharmaceutical Industries Co. PLCASE: HPIC | $42.48M | JD3.17 | -0.63% |
| Tsubota Laboratory IncorporatedTSE: 4890 | $42.35M | ¥260.00 | +3.59% |
| Veru Inc.NasdaqCM: VERU | $41.94M | $2.41 | -2.24% |
| Orion Infusion LimitedDSE: ORIONINFU | $41.46M | Tk250.80 | -2.68% |
Figures last refreshed Oct 11, 2026.